Equibles does not estimate personal net worth.
Get an email with a short summary when Neumora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NMRA alertsAbout Carol Suh
Carol Suh is recorded as COO at Neumora Therapeutics, Inc. (NMRA). The newest filing on record that lists Carol Suh as COO at Neumora Therapeutics, Inc. (NMRA) is dated April 25, 2024. Neumora Therapeutics, Inc. reported in an 8-K filed February 13, 2025 that Carol Suh was appointed Chief Strategy Officer, effective February 14, 2025. Neumora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neumora Therapeutics, Inc. includes Joshua Pinto (CEO and Board Member), Paul L. Berns (CEO, Chairman and Board Member), Michael Milligan (CFO) and 7 others.
“Carol Suh will transition from the role of Chief Operating Officer to Chief Strategy Officer”
Affiliation history
-
Current
2025-02-14–present
-
Current
Start not stated–present
Last confirmed April 25, 2024
Company network
Leadership on record at Neumora Therapeutics, Inc.
- Joshua Pinto CEO, Board Member
- Paul L. Berns CEO, Chairman, Board Member
- Michael Milligan CFO
- Bill Aurora COO
- Jason Duncan General Counsel
- Alaa Halawa Board Member
- David Piacquad Board Member
- Kristina Burow Board Member
- Matthew Fust Board Member
- Maykin Ho Board Member